Join to access to all OVN content. Join for Free
Why Clinicians Make Great MSLs
Medical Science Liaison MSL role transition clinician to MSL networking for MSLs MSL career advice

Why Clinicians Make Great MSLs


Share This Article


Summary

In this episode, Tom Caravela is joined by Dawn O'Reilly, who shares her journey into the MSL role and offers valuable insights for clinicians transitioning into this field. Dawn discusses why clinicians are well-suited for MSL positions and provides advice for those making the switch. She reflects on lessons learned, emphasizing the importance of patience and the skills necessary for new MSLs. The conversation also covers the unique challenges of navigating the MSL role during the pandemic and the shift to virtual work. Dawn concludes with her future aspirations and the significance of mentoring, encouraging listeners to pursue their goals.

Dawn O'Reilly, Ph.D., MMS, PA-C, Medical Science Liaison at Biodesix discusses why and how clinicians make great Medical Science Liaisons

Dawn shares…

πŸ‘‰ Tips and advice to transition to an MSL role

πŸ‘‰ What skills clinicians need to develop for industry roles

πŸ‘‰ The importance of networking in your career and job search

πŸ‘‰ What challenges you can expect as an MSL

πŸ‘‰ Why patience is so critical

Click for Source
Medical Science Liaison, MSL role transition, clinician to MSL, networking for MSLs, MSL career advice

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN